|Bid||7.47 x 1400|
|Ask||7.88 x 1000|
|Day's range||7.49 - 7.73|
|52-week range||7.48 - 14.14|
|Beta (5Y monthly)||1.28|
|PE ratio (TTM)||N/A|
|Earnings date||04 Aug 2021 - 09 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||9.63|
Puma Biotech (PBYI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LOS ANGELES, July 26, 2021--Puma Biotechnology and Athyrium Capital have entered into an agreement for the issuance of up to $125 million of notes in two tranches.
LOS ANGELES, July 22, 2021--Puma Biotechnology will host a conference call at 1:30 p.m. PT on Aug. 5 following the release of its second quarter 2021 financial results.